GILD insider transaction filings
GILEAD SCIENCES, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen GILD transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Bluestone Jeffrey — Director | Option exercise (M): 1,165 @ $67.45 · Sale (S): 1,165 @ $143.75 · Option exercise (M): 1,816 @ $67.45 · Sale (S): 1,816 @ $144.92 · Option exercise (M): 1,658 @ $67.45 · Sale (S): 1,658 @ $145.73 · +6 more | EDGAR |
| 2026-08-18 | 4 | Dickinson Andrew D — Chief Financial Officer | Sale (S): 3,000 @ $138.36 | EDGAR |
| 2026-08-18 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Option exercise (M): 23,110 @ $66.64 · Option exercise (M): 1,890 @ $72.34 · Sale (S): 16,530 @ $137.37 · Sale (S): 11,470 @ $138.04 · Option exercise (M): 23,110 (derivative) @ $0 · Option exercise (M): 1,890 (derivative) @ $0 | EDGAR |
| 2026-08-11 | 4 | Cain Wettan Keeley M — EVP Gen Counsel, Legal & Comp | Option exercise (M): 6,002 · Tax withholding (F): 2,908 @ $133.06 · Option exercise (M): 6,002 (derivative) | EDGAR |
| 2026-08-04 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Sale (S): 6,700 @ $129.66 · Sale (S): 7,700 @ $130.80 · Sale (S): 600 @ $131.34 | EDGAR |
| 2026-07-16 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Sale (S): 3,000 @ $129.92 | EDGAR |
| 2026-07-16 | 4 | Dickinson Andrew D — Chief Financial Officer | Sale (S): 3,000 @ $129.93 | EDGAR |
| 2026-07-02 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Sale (S): 11,900 @ $126.09 · Sale (S): 3,100 @ $127.08 | EDGAR |
| 2026-06-16 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Sale (S): 1,480 @ $123.42 · Sale (S): 1,070 @ $124.00 · Sale (S): 450 @ $125.40 | EDGAR |
| 2026-06-16 | 4 | Dickinson Andrew D — Chief Financial Officer | Sale (S): 3,000 @ $125.40 | EDGAR |
| 2026-06-11 | 4 | Cain Wettan Keeley M — EVP Gen Counsel, Legal & Comp | Option exercise (M): 589 · Tax withholding (F): 283 @ $121.48 · Option exercise (M): 589 (derivative) | EDGAR |
| 2026-06-11 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Option exercise (M): 2,796 · Tax withholding (F): 1,341 @ $121.48 · Option exercise (M): 2,796 (derivative) | EDGAR |
| 2026-06-11 | 4 | Berger Dietmar — Chief Medical Officer | Option exercise (M): 533 · Tax withholding (F): 263 @ $121.48 · Option exercise (M): 533 (derivative) | EDGAR |
| 2026-06-11 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Option exercise (M): 8,779 · Tax withholding (F): 4,213 @ $121.48 · Option exercise (M): 8,779 (derivative) | EDGAR |
| 2026-06-11 | 4 | Dickinson Andrew D — Chief Financial Officer | Option exercise (M): 2,796 · Tax withholding (F): 1,341 @ $121.48 · Option exercise (M): 2,796 (derivative) | EDGAR |
| 2026-06-02 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Sale (S): 10,900 @ $131.10 · Sale (S): 3,062 @ $132.22 · Sale (S): 1,038 @ $132.97 | EDGAR |
| 2026-05-18 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Option exercise (M): 25,000 @ $66.64 · Sale (S): 7,749 @ $130.29 · Sale (S): 11,177 @ $131.19 · Sale (S): 8,374 @ $132.23 · Sale (S): 700 @ $132.75 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Dickinson Andrew D — Chief Financial Officer | Sale (S): 3,000 @ $132.27 | EDGAR |
| 2026-05-04 | 4 | Bluestone Jeffrey — Director | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Horning Sandra — Director | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Kramer Kelly A. — Director | Grant/award (A): 1,146 (derivative) @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | MANWANI HARISH — Director | Grant/award (A): 1,146 @ $0 · Tax withholding (F): 224 @ $130.84 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Rodriguez Javier — Director | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | WELTERS ANTHONY — Director | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | LOVE TED W — Director | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | BARTON JACQUELINE K — Director | Grant/award (A): 1,146 @ $0 · Grant/award (A): 4,884 (derivative) @ $0 | EDGAR |
| 2026-04-29 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Sale (S): 6,950 @ $128.79 · Sale (S): 3,050 @ $130.01 | EDGAR |
| 2026-04-16 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Sale (S): 3,000 @ $140.96 | EDGAR |
| 2026-04-16 | 4 | Dickinson Andrew D — Chief Financial Officer | Sale (S): 3,000 @ $140.96 | EDGAR |
| 2026-03-30 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Sale (S): 10,000 @ $136.82 | EDGAR |
| 2026-03-17 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Sale (S): 3,000 @ $144.23 | EDGAR |
| 2026-03-17 | 4 | Dickinson Andrew D — Chief Financial Officer | Sale (S): 3,000 @ $144.23 | EDGAR |
| 2026-03-12 | 4 | Cain Wettan Keeley M — EVP Gen Counsel, Legal & Comp | Option exercise (M): 1,246 · Tax withholding (F): 606 @ $148.56 · Option exercise (M): 1,246 (derivative) · Grant/award (A): 5,050 (derivative) · Grant/award (A): 18,885 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Burkhart Erin — SVP, Controllership | Grant/award (A): 2,355 (derivative) · Grant/award (A): 5,455 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Option exercise (M): 6,617 · Tax withholding (F): 3,216 @ $148.56 · Option exercise (M): 6,617 (derivative) · Grant/award (A): 9,590 (derivative) · Grant/award (A): 35,880 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Berger Dietmar — Chief Medical Officer | Option exercise (M): 2,133 · Tax withholding (F): 1,063 @ $148.56 · Option exercise (M): 2,133 (derivative) · Grant/award (A): 8,415 (derivative) · Grant/award (A): 31,475 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Option exercise (M): 20,026 · Tax withholding (F): 9,767 @ $148.56 · Option exercise (M): 20,026 (derivative) · Grant/award (A): 32,815 (derivative) · Grant/award (A): 122,755 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Dickinson Andrew D — Chief Financial Officer | Option exercise (M): 6,469 · Tax withholding (F): 3,147 @ $148.56 · Option exercise (M): 6,469 (derivative) · Grant/award (A): 9,590 (derivative) · Grant/award (A): 35,880 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Cain Wettan Keeley M — EVP Gen Counsel, Legal & Comp | Grant/award (A): 470 @ $0 | EDGAR |
| 2026-03-02 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Grant/award (A): 11,090 @ $0 | EDGAR |
| 2026-03-02 | 4 | Berger Dietmar — Chief Medical Officer | Grant/award (A): 8,530 @ $0 | EDGAR |
| 2026-03-02 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Grant/award (A): 38,396 @ $0 · Sale (S): 3,481 @ $144.04 · Sale (S): 6,419 @ $145.18 · Sale (S): 100 @ $145.71 | EDGAR |
| 2026-03-02 | 4 | Dickinson Andrew D — Chief Financial Officer | Grant/award (A): 11,090 @ $0 | EDGAR |
| 2026-02-18 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Option exercise (M): 25,000 @ $66.64 · Sale (S): 18,405 @ $154.18 · Sale (S): 9,395 @ $154.91 · Sale (S): 200 @ $155.62 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Dickinson Andrew D — Chief Financial Officer | Sale (S): 3,000 @ $154.43 | EDGAR |
| 2026-02-06 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Option exercise (M): 115,640 @ $66.01 · Sale (S): 115,640 @ $150 · Option exercise (M): 115,640 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Mercier Johanna — Chief Comm & Corp Aff Officer | Grant/award (A): 44,867 @ $0 · Tax withholding (F): 24,800 @ $143.28 | EDGAR |
| 2026-02-05 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Grant/award (A): 131,675 @ $0 · Tax withholding (F): 74,461 @ $143.28 | EDGAR |
| 2026-02-05 | 4 | Dickinson Andrew D — Chief Financial Officer | Grant/award (A): 44,867 @ $0 · Tax withholding (F): 24,802 @ $143.28 | EDGAR |
| 2026-01-29 | 4 | O'Day Daniel Patrick — Chairman & CEO, Director | Sale (S): 5,032 @ $139.54 · Sale (S): 4,968 @ $140.24 | EDGAR |
Recent 8-K events — GILEAD SCIENCES, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GILD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →